Print
17 July 2015
Marchmont Innovation News
An international project led by a Russian scientist received the top award in the category of “Nanotechnology, New Materials and Production” at the most recent EU Nanotech Forum, Russia’s Sputnik News reported .
The project is called “Nanotechnological Toolkits for Multi-Modal Disease Diagnostics and Treatment Monitoring (NAMDIATREAM).” The semiconductor nanocrystals project platform is directed by Professor Igor Nabiev, the leading scientist of the laboratory of nano-bioengineering at Russia's National Research Nuclear University (MEPhI) and Professor at Université de Reims Champagne-Ardenne in France.
NAMDIATREAM is said to have successfully developed cutting-edge devices for early diagnostics of several of the most common cancers, including lung, breast and prostate cancer, which affect over 4.5 million people annually.
The pioneering technology will detect biomarkers of abnormal cell growths during the early stages of their development, thus significantly increasing the chances of fighting cancer.
In total, there were over 1,000 projects presented at the 2015 EuroNanoForum.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.